Renaissance Capital logo

Journey Medical Priced, Nasdaq: DERM

Owns a portfolio of acquired drugs marketed for skin conditions.

Industry: Health Care

Latest Trade: $2.79 0.00 (0.0%)

First Day Return: -5.0%

Return from IPO: -72.1%

Industry: Health Care

Journey Medical Corporation is a commercial-stage pharmaceutical company founded in October 2014 that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Our current portfolio includes five branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the U.S. We are managed and led by experienced life science executives with a track record of creating value for their stakeholders and bringing novel medicines to the market, enabling patients to experience increased quality of life, and enabling physicians and other licensed medical professionals to provide better care for their patients. We aim to acquire rights to future products by licensing or otherwise acquiring an ownership interest in, funding the research and development of, and eventually commercializing, those products through our exclusive field sales force. For the 2020 fiscal year, we had revenue of $44.5 million for our products that were marketed as of the end of 2020 and for the six months ended June 30, 2021, we had revenue of $26.0 million for our marketed products. We expect to continue to market these prescription drugs in the U.S. through our field sales force.
more less
IPO News for Journey Medical
more
IPO Data
IPO File Date 10/22/2021
Offer Price $10.00
Price Range $10.00 - $12.00
Offer Shares (mm) 3.5
Deal Size ($mm) $35
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/11/2021
Offer Price $10.00
Price Range $10.00 - $12.00
Offer Shares (mm) 3.5
Deal Size ($mm) $35
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Scottsdale, AZ
Founded 2014
Employees 82
Website www.jmcderm.com